Evidence map›Paper›PMID 15870282›Full record

ArticleMolecular and cellular biology2005

Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4.

Tara J Dillon, Kendall D Carey, Scott A Wetzel, David C Parker, Philip J S Stork

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Article
  6. Review
  7. Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment.Expert review of endocrinology & metabolism · 2019
    Review
  8. Article
  9. Article
  10. Review
  11. Regulatory T cells require TCR signaling for their suppressive function.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tara J DillonVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Kendall D Carey
Scott A Wetzel
David C Parker
Philip J S Stork
Oregon Health & Science University · US

Funding

Imaging and Function of the Immunological SynapseR01AI050823 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI PARKER, DAVID C · 2002 to 2012
$2.9M
The small G protein Rap 1 in T cell activation/anergyR01AI047337 · NIAID · OREGON HEALTH AND SCIENCE UNIVERSITY · PI STORK, PHILIP J.S. · 2001 to 2005
$1.5M
NIAID NIH HHS AI047337NIAID NIH HHS AI50823NIAID NIH HHS R01 AI047337NIAID NIH HHS R01 AI050823
6 · The paper itself

Abstract

The mitogen-activated protein kinase extracellular signal-regulated kinase (ERK) is activated following engagement of the T-cell receptor and is required for interleukin 2 (IL-2) production and T-cell proliferation. This activation is enhanced by stimulation of the coreceptor CD28 and inhibited by the coreceptor CTLA-4. We show that the small G protein Rap1 is regulated in the opposite manner; it is inhibited by CD28 and activated by CTLA-4. Together, CD3 and CTLA-4 activate Rap1 in a sustained manner. To delineate T-cell function in the absence of Rap1 activity, we generated transgenic mice expressing Rap1GAP1, a Rap1-specific GTPase-activating protein. Transgenic mice showed lymphadenopathy, and transgenic T cells displayed increased ERK activation, proliferation, and IL-2 production. More significantly, the inhibitory effect of CTLA-4 on T-cell function in Rap1GAP1-transgenic T cells was reduced. We demonstrate that CTLA-4 activates Rap1, and we propose that intracellular signals from CTLA-4 antagonize CD28, at least in part, at the level of Rap1.

Indexed as

AnimalsAntigen-Presenting CellsAntigens, CDAntigens, DifferentiationCell AdhesionCell LineCTLA-4 AntigenEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFemaleGTPase-Activating ProteinsHumansLymphocyte ActivationMaleMiceMice, TransgenicAntigens, CDAntigens, DifferentiationCTLA-4 AntigenCTLA4 protein, humanCtla4 protein, mouseExtracellular Signal-Regulated MAP KinasesGTPase-Activating ProteinsHRAS protein, humanProto-Oncogene Proteins p21(ras)rap1 GTP-Binding Proteins

Identifiers

PMID15870282
PMCPMC1087740
OpenAlexW2125891998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.